Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...
In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma.
A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback